home / stock / tenx / tenx short
Short Information | Tenax Therapeutics Inc. (NASDAQ:TENX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 82,999 |
Total Actual Volume | 386,498 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 4,150 |
Average Short Percentage | 21.28% |
Is there a TENX Short Squeeze or Breakout about to happen?
See the TENX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-31-2024 | $3.59 | $3.46 | $3.59 | $3.45 | 22,905 | 4,427 | 19.33% |
05-30-2024 | $3.58 | $3.5 | $3.6 | $3.46 | 9,229 | 1,000 | 10.84% |
05-29-2024 | $3.51 | $3.535 | $3.5908 | $3.5 | 12,707 | 596 | 4.69% |
05-28-2024 | $3.512 | $3.5 | $3.61 | $3.5 | 6,468 | 395 | 6.11% |
05-24-2024 | $3.58 | $3.51 | $3.6293 | $3.5 | 15,990 | 2,782 | 17.4% |
05-23-2024 | $3.56 | $3.56 | $3.74 | $3.52 | 19,037 | 6,039 | 31.72% |
05-22-2024 | $3.64 | $3.62 | $3.7056 | $3.6 | 8,250 | 944 | 11.44% |
05-21-2024 | $3.82 | $3.67 | $3.82 | $3.6058 | 14,594 | 1,720 | 11.79% |
05-20-2024 | $3.6 | $3.77 | $3.7914 | $3.6 | 13,949 | 3,872 | 27.76% |
05-17-2024 | $3.64 | $3.549 | $3.64 | $3.52 | 13,419 | 5,517 | 41.11% |
05-16-2024 | $3.6 | $3.55 | $3.6949 | $3.54 | 32,088 | 2,990 | 9.32% |
05-15-2024 | $3.61 | $3.59 | $3.61 | $3.49 | 24,168 | 8,455 | 34.98% |
05-14-2024 | $3.44 | $3.47 | $3.63 | $3.44 | 52,885 | 7,283 | 13.77% |
05-13-2024 | $3.51 | $3.55 | $3.65 | $3.51 | 26,112 | 5,129 | 19.64% |
05-10-2024 | $3.64 | $3.585 | $3.68 | $3.47 | 10,478 | 1,304 | 12.45% |
05-09-2024 | $3.64 | $3.57 | $3.64 | $3.55 | 12,452 | 3,680 | 29.55% |
05-08-2024 | $3.57 | $3.55 | $3.6345 | $3.5 | 11,490 | 4,994 | 43.46% |
05-07-2024 | $3.77 | $3.53 | $3.77 | $3.45 | 44,631 | 13,799 | 30.92% |
05-06-2024 | $3.9 | $3.71 | $3.9 | $3.65 | 21,848 | 3,443 | 15.76% |
05-03-2024 | $3.7884 | $3.84 | $3.86 | $3.78 | 13,798 | 4,630 | 33.56% |
News, Short Squeeze, Breakout and More Instantly...
Tenax Therapeutics Inc. Company Name:
TENX Stock Symbol:
NASDAQ Market:
Tenax Therapeutics Inc. Website:
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF ...